Garlic
Allium sativum
A kitchen staple with modest, real effects on blood pressure and cholesterol.
Moderate evidence
🫀Heart & Metabolic
Evidence tier
Moderate
Research weight
Citations
21 verified / 21
Classification
Heart & Metabolic
❝
What the evidence says. Several controlled trials; effects real but modest or context-dependent.
What is Garlic?
Garlic (Allium sativum) is a heart and metabolic supplement used for small but consistent reductions in systolic and diastolic blood pressure across meta-analyses (roughly 2-4 mmhg). NutriDex grades the human evidence as Moderate. Garlic (Allium sativum) is a culinary bulb whose organosulfur compounds, chiefly allicin and its derivatives, are thought to drive its cardiovascular effects. Multiple recent meta-analyses of randomized trials show that garlic supplementation produces small but statistically significant reductions in blood pressure (about 2-4 mmHg systolic) and in total cholesterol, LDL, and triglycerides, with the largest benefits seen in adults who already have elevated risk factors. The effects are real but modest, and garlic should be viewed as an adjunct rather than a replacement for proven medications. Standardized garlic powder and aged garlic extract are the best-studied forms, since allicin is unstable and depends on how garlic is prepared. The most important safety consideration is garlic's antiplatelet activity, which can add to the bleeding risk of anticoagulants and is relevant around surgery. Overall the evidence supports a genuine, if minor, role in supporting heart and metabolic health.
Purported Benefits
✓Small but consistent reductions in systolic and diastolic blood pressure across meta-analyses (roughly 2-4 mmHg)
✓Modest lowering of total cholesterol, LDL, and triglycerides, with the clearest signal in people with elevated baseline levels
✓Slight, statistically significant improvements in fasting glucose and HDL in pooled trial data
✓Generally well tolerated as a whole food, with cardiovascular markers favored most in higher-risk adults
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Blood pressure reductionMany RCT meta-analyses (incl. trial-sequential analysis) consistently show ~2-4 mmHg systolic drop, larger in hypertensives. | Strong | ↑ benefit · small | 6 |
| Cholesterol / lipid loweringPooled RCTs show modest reductions in total cholesterol and LDL; clearest in those with elevated baseline lipids. | Strong | ↑ benefit · small | 4 |
| Glycemic control (T2D)One RCT meta-analysis found reduced fasting glucose and HbA1c in type 2 diabetes; limited trial base. | Moderate | ↑ benefit · small | 1 |
| Coronary plaque progressionSmall year-long aged-garlic RCTs show slowed calcification / vulnerable-plaque regression on CT; single-center, surrogate endpoints. | Preliminary | ↑ benefit · small | 3 |
| Cancer risk reductionMeta-analysis found no significant association between garlic supplements or allium intake and overall cancer risk. | Moderate | — no effect · negligible | 1 |
| Common cold preventionCochrane found a single low-quality trial: fewer colds but no faster recovery; evidence judged insufficient. | Preliminary | ↔ mixed | 1 |
| Bleeding / antiplatelet riskCase reports link perioperative bleeding to garlic's platelet inhibition; agencies advise caution with anticoagulants. | Preliminary | ⚠ risk | 1 |
Dosing & Compounds
Typical Dose
Garlic powder 300-900 mg/day (standardized to ~1.8-5.4 mg allicin), or aged garlic extract ~600-1,200 mg/day; equivalent to roughly one to two fresh cloves daily.
Active Compounds
Safety & Cautions
Garlic is safe as a food, but supplemental doses can cause breath and body odor, heartburn, abdominal pain, flatulence, nausea, and occasional allergic reactions; raw garlic applied to skin can cause burns. Its key risk is antiplatelet/anticoagulant activity: garlic supplements may increase bleeding risk and can potentiate warfarin, clopidogrel, aspirin, and other blood thinners. Discontinue garlic supplements at least 7 days before surgery or dental procedures. People with bleeding disorders, those on anticoagulant or antiplatelet therapy, and anyone awaiting surgery should avoid supplemental garlic or use it only under medical supervision. Garlic may also lower blood glucose and blood pressure, so caution is warranted when combined with antidiabetic or antihypertensive medications. Pregnant and breastfeeding women should not exceed normal dietary amounts, as the safety of higher supplemental doses is not established; garlic may also reduce levels of some drugs such as saquinavir. Educational only — always check with your doctor or pharmacist before combining Garlic with any medicine.
Garlic drug interactions
Known or theoretical interactions between Garlic and common medications — educational, not exhaustive. Always check with your doctor or pharmacist before combining Garlic with any medicine.
Caution
Warfarin & antiplatelet drugs
Concentrated garlic supplements may increase bleeding risk with blood thinners.
Garlic constituents inhibit platelet aggregation, enhancing anticoagulant/antiplatelet activity. NIH ODS — Garlic
Monitor
Blood-pressure drugs
Garlic may modestly lower blood pressure, adding to antihypertensive drugs.
Organosulfur compounds promote nitric-oxide vasodilation, giving mild additive BP lowering. NCCIH — Garlic
Key Studies ★ 21 studies
Systematic review / meta-analysis
108 trials, 7,137 participants
✓ PubMed
This 2026 comprehensive meta-analysis of RCTs found garlic supplementation reduced systolic BP by 3.71 mmHg, diastolic BP by 1.97 mmHg, total cholesterol by 10.21 mg/dL, and LDL by 5.90 mg/dL versus control.
Systematic review / meta-analysis
19 RCTs
✓ PubMed
A 2025 dose-response, GRADE-assessed meta-analysis found aged garlic extract significantly reduced systolic blood pressure (WMD -2.49 mmHg) and LDL cholesterol (WMD -4.41 mg/dL), confirming modest effects.
meta-analysis
4 RCTs, 212 participants
✓ Full text
This 2023 meta-analysis of RCTs found garlic supplementation significantly reduced ALT (MD -3.76 U/L) and AST (MD -3.62 U/L) in patients with chronic liver disease/NAFLD, with low heterogeneity.
Meta-analysis
Frontiers/Updated MA & TSA 2025
✓ Full text
Across 12 reports (405 garlic vs 333 placebo), garlic extracts lowered systolic BP by 8.12 mmHg (95% CI -10.95 to -5.28) and diastolic BP by 4.26 mmHg (95% CI -5.99 to -2.52) in hypertensives; trial sequential analysis indicated sufficient evidence had been reached.
Meta-analysis
Aged Garlic MA (hypertensives) 2024
✓ PubMed
Pooling 9 RCTs (584 hypertensive participants), aged garlic extract reduced systolic BP by 4.03 mmHg and diastolic BP by 1.44 mmHg versus control.
Meta-analysis
Ma 2025
✓ PubMed
Updated meta-analysis with trial sequential analysis (12 trials, 405 garlic vs 333 placebo) in hypertensive patients found garlic significantly lowered systolic BP by 8.12 mmHg (95% CI -10.95 to -5.28) and diastolic BP by 4.26 mmHg (95% CI -5.99 to -2.52); TSA confirmed evidence is conclusive and further trials are not needed.
Meta-analysis
Du 2024
✓ PubMed
Meta-analysis of 21 RCTs in dyslipidemic patients found garlic significantly reduced total cholesterol -0.64 mmol/L, LDL-C -0.44 mmol/L, and triglycerides -0.17 mmol/L while slightly raising HDL-C +0.04 mmol/L; effects greater in patients over 50 years and with garlic oil versus powder.
meta-analysis
22 studies (allium vegetables) and 10 studies (garlic supplements)
✓ Full text
This 2022 systematic review and meta-analysis found no significant association between allium vegetable intake (RR 0.97, 95% CI 0.92-1.03) or garlic supplements (RR 0.97, 95% CI 0.84-1.12) and overall cancer risk, indicating garlic does not meaningfully reduce cancer incidence.
meta-analysis
9 RCTs, 768 type 2 diabetes patients
✓ PubMed
This 2017 meta-analysis of RCTs found garlic supplementation significantly reduced fasting blood glucose and glycated hemoglobin (HbA1c) at 12 and 24 weeks in patients with type 2 diabetes, alongside improvements in total cholesterol and LDL.
meta-analysis
16 RCTs (CRP from 13 studies, TNF from 7, IL-6 from 5)
✓ PubMed
This 2019 systematic review and meta-analysis of RCTs in The Journal of Nutrition found garlic supplementation significantly reduced circulating C-reactive protein (WMD -0.61 mg/L), tumor necrosis factor (WMD -0.26 ng/L), and interleukin-6 (WMD -0.73 ng/L) in adults, indicating an anti-inflammatory effect.
Systematic review
Lissiman 2014 (Cochrane)
✓ PubMed
Cochrane systematic review found only one eligible RCT (n=146): a garlic supplement (180 mg allicin/day for 12 weeks) was associated with fewer common cold occurrences (24 vs 65 with placebo, P<0.001) and fewer days of illness, but days-to-recovery were similar; authors concluded evidence is insufficient and largely low-quality.
systematic review
1 RCT, 146 participants (Cochrane review)
✓ Full text
This Cochrane systematic review found only one eligible trial, in which daily garlic for 12 weeks reduced common cold occurrences (24 vs 65 in placebo) but did not shorten recovery time, concluding evidence is insufficient and of poor quality.
Meta-analysis
Long-term garlic safety/efficacy MA
✓ Full text
A meta-analysis of 10 RCTs reported significant reductions in systolic BP (-4.21 mmHg) and diastolic BP (-3.13 mmHg) with garlic versus control, evaluating long-term garlic as an adjunctive hypertension treatment.
RCT
Optimized Aged Garlic RCT 2023
✓ Full text
A randomized, triple-blind controlled trial tested an optimized aged garlic extract as add-on therapy in subjects with grade I hypertension already on antihypertensive drugs.
rct
1 RCT, 32 obese women completed
✓ Full text
This 2022 double-blind RCT in Frontiers in Nutrition found that garlic extract (800 mg/day, ~2,200 mcg allicin) for 2 months on a low-calorie diet significantly increased beneficial gut Bifidobacterium (P=0.005), though weight loss did not differ significantly between garlic and placebo groups.
RCT
Wlosinska 2020 (AGE RCT)
✓ PubMed
Single-center double-blind RCT (n=104, Framingham risk >=10) of aged garlic extract 2400 mg/day vs placebo for 1 year found AGE significantly slowed coronary artery calcification progression (OR 2.95, 95% CI 1.05-8.27), lowered IL-6, blood glucose, and reduced systolic BP from 148 to 140 mmHg; no side effects.
Government health agency summary
Narrative review (NCCIH consumer summary)
✓ Source
The US NCCIH concludes that evidence suggests garlic supplements may lower blood pressure and cholesterol only to a small extent, and warns that garlic supplements may increase bleeding risk.
rct
1 RCT, 55 patients with metabolic syndrome
✓ PubMed
This 2016 prospective randomized double-blind trial found that 2,400 mg/day aged garlic extract over ~1 year significantly regressed vulnerable low-attenuation coronary plaque on CT angiography versus placebo (-1.5% vs +0.2%, P=0.0049), a marker of plaque stabilization.
RCT
Shaikh 2019 (Budoff lab AGE RCT)
✓ PubMed
Double-blind placebo-controlled RCT in 80 patients with diabetes given aged garlic extract 2400 mg/day vs placebo for 1 year, with serial coronary CT angiography, showed significant regression of low-attenuation (vulnerable) plaque in the AGE group versus progression in placebo (P=0.0415); no significant change in total, fibrous, or fibro-fatty plaque.
Randomized controlled trial
Meta-analysis
✓ Full text
An optimized aged garlic extract trial and pooled analyses report favorable shifts in cardiovascular risk markers, including LDL and blood pressure, in moderately hypercholesterolemic and hypertensive subjects.
Case report / clinical letter
Case report / clinical letter (2 surgical cases)
✓ Full text
This Royal College of Surgeons letter documents perioperative capillary bleeding linked to garlic supplements via ajoene's irreversible platelet inhibition, recommending discontinuation 7 days before surgery.